Inter-domain communication in SARS-CoV-2 spike proteins controls protease-triggered cell entry

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved..

SARS-CoV-2 continues to evolve into variants of concern (VOC), with greatest variability in the multidomain, entry-facilitating spike proteins. To recognize the significance of adaptive spike protein changes, we compare variant SARS-CoV-2 virus particles in several assays reflecting authentic virus-cell entry. Virus particles with adaptive changes in spike amino-terminal domains (NTDs) are hypersensitive to proteolytic activation of membrane fusion, an essential step in virus-cell entry. Proteolysis is within fusion domains (FDs), at sites over 10 nm from the VOC-specific NTD changes, indicating allosteric inter-domain control of fusion activation. In addition, NTD-specific antibodies block FD cleavage, membrane fusion, and virus-cell entry, suggesting restriction of inter-domain communication as a neutralization mechanism. Finally, using structure-guided mutagenesis, we identify an inter-monomer β sheet structure that facilitates NTD-to-FD transmissions and subsequent fusion activation. This NTD-to-FD axis that sensitizes viruses to infection and to NTD-specific antibody neutralization provides new context for understanding selective forces driving SARS-CoV-2 evolution.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:39

Enthalten in:

Cell reports - 39(2022), 5 vom: 03. Mai, Seite 110786

Sprache:

Englisch

Beteiligte Personen:

Qing, Enya [VerfasserIn]
Li, Pengfei [VerfasserIn]
Cooper, Laura [VerfasserIn]
Schulz, Sebastian [VerfasserIn]
Jäck, Hans-Martin [VerfasserIn]
Rong, Lijun [VerfasserIn]
Perlman, Stanley [VerfasserIn]
Gallagher, Tom [VerfasserIn]

Links:

Volltext

Themen:

CP: Microbiology
Coronavirus
EC 3.4.-
Journal Article
Membrane fusion
Peptide Hydrolases
SARS-CoV-2
Spike Glycoprotein, Coronavirus
Spike protein
Spike protein, SARS-CoV-2
Virus entry
Virus evolution
Virus neutralization
Virus variation

Anmerkungen:

Date Completed 06.05.2022

Date Revised 28.01.2023

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.celrep.2022.110786

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM340059672